Order last week is only partial rescheduling, making ‘an already complex process more confusing,’ expert says

The Trump administration is making good on its promise to reschedule cannabis , but only partially – raising plenty of questions for those in the cannabis industry.

Todd Blanche , the acting attorney general, signed an order last week that removes products sold under state medical cannabis licenses and FDA approved cannabis products from schedule I – defined as substances with no accepted medical use, to schedule III – which includes legal but regulated substances including certain doses of Tylenol with codeine and ketamine.